This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Disturbances of memory, behavior, cognition, and seizures can result from immune-mediated encephalitides. These disorders can be paraneoplastic or not and may associate with several antibodies.1 Recently, a treatment-responsive paraneoplastic encephalitis that associates with antibodies to NR1/NR2 heteromers of the NMDA receptor (NMDAR) was reported.2 Patients were young women with teratomas, usually of the ovary, who presented with prominent psychiatric symptoms, and less frequently with features of limbic encephalitis. We report a man with treatment-responsive limbic encephalitis and antibodies to NR1/NR2 heteromers.
Case report.
For 3 months this 53-year-old man had progressive short-term memory deficits and disorientation that forced him to leave his job. During the month before hospital admission he had multiple episodes compatible with partial complex seizures. He had no past medical history of interest. The neurologic examination only revealed short-term memory deficits and impairment of temporal orientation. Blood cell count, general chemistry, B12, folic acid, thyroid function test, thyroglobulin antibodies, RPR, Lyme serology, antibodies to double stranded DNA, and SSA/Ro and SSB/La were unrevealing. CSF analysis showed 5 WBC/μL (100% lymphocytes) and normal glucose and protein concentration. Serum and CSF disclosed the same oligoclonal IgG bands. Paraneoplastic antineuronal and VGKC antibodies were negative. EEG demonstrated bilateral temporal lobe epileptic activity. MRI of the brain revealed noncontrast enhancing T2 and FLAIR hyperintensities involving the medial aspect of the temporal lobes and nonspecific hyperintensities in the frontal lobes (figure, A). Ultrasound of the testis, CT of the chest, abdomen and …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
